• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

21
4
3
3
2

COUNTRY

2
2
2
1
1

CATEGORIES

  • 25
  • 14
  • 6
  • 5
  • 4
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL…

PRICE

6
7
10
64

PUBLISHED

1
2
18
64

PRODUCT TYPE

58
6

Search "General Pharmaceuticals Ltd.-Therapeutic Competitors Report" returned 64 results.

PRODUCT TITLE

Gastrointestinal Disorders Therapeutics Market to 2018 - Novel Agents Targeting Irritable Bowel Syndrome (IBS), Chronic Constipation (CC) and Ulcerative Colitis (UC) to Reinvigorate the Market

GBI Research, the leading business intelligence provider, has released its latest research, “Gastrointestinal Disorders Therapeutics Market to 2018 - Novel Agents Targeting Irritable Bowel Syndrome...

November 2012
FROM

Osiris Therapeutics, Inc. (OSIR) - Financial and Strategic SWOT Analysis Review

Osiris Therapeutics, Inc. (OSIR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

April 2014
FROM
Global Pharmaceutical Survey 2012–2013: Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry Global Pharmaceutical Survey 2012–2013: Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry - Product Thumbnail Image

Global Pharmaceutical Survey 2012–2013: Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry

“Global Pharmaceutical Survey 2012–2013: Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry” is a new report by ICD Research that analyzes how Pharmaceutical...

March 2012
FROM
Global Pharmaceutical Survey 2012–2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry Global Pharmaceutical Survey 2012–2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry - Product Thumbnail Image

Global Pharmaceutical Survey 2012–2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry

“Global Pharmaceutical Survey 2012–2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry” is a new report by ICD Research that analyzes how Pharmaceutical industry...

March 2012
FROM

Monoclonal Antibodies Market in Rheumatoid Arthritis to 2018 - Market Characterized by Large and Diversified Pipeline and Low Threat of Biosimilar Sales Erosion

The currently marketed monoclonal antibodies are clinically and commercially highly successful products in the rheumatoid arthritis market, constituting four of the global top 20 best-selling drugs...

January 2013
FROM

Taro Pharmaceutical Industries Ltd. (TARO) - Financial and Strategic SWOT Analysis Review

Taro Pharmaceutical Industries Ltd. (TARO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has...

July 2014
FROM

Sunovion Pharmaceuticals Inc. - Strategic SWOT Analysis Review

Sunovion Pharmaceuticals Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains...

March 2015
FROM

The Future of Biosimilars - Market Forecasts to 2015, Opportunity Analysis and Regulatory Pathways

“The Future of Biosimilars - Market Forecasts to 2015, Opportunity Analysis and Regulatory Pathways” provides insights on the biosimilars market revenues and growth until 2015 Further, the distribution...

December 2009
FROM

Healthcare, Regulatory and Reimbursement Landscape - Australia

Healthcare, Regulatory and Reimbursement Landscape - Australia Summary GlobalData, the industry analysis specialist, has released its new report, “Healthcare, Regulatory and Reimbursement Landscape...

July 2012
FROM

Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2023

Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2023 Kalorama Information's Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2023 takes a considered...

April 2014
FROM

Breast Cancer - Pipeline Review, H2 2014

Breast Cancer - Pipeline Review, H2 2014 Summary This, ‘Breast Cancer - Pipeline Review, H2 2014’, provides an overview of the Breast Cancer’s therapeutic pipeline. This report provides comprehensive...

November 2014
FROM

Healthcare, Regulatory and Reimbursement Landscape - Turkey

Healthcare, Regulatory and Reimbursement Landscape - Turkey Summary GlobalData, the industry analysis specialist, has released its latest report, “Healthcare, Regulatory and Reimbursement Landscape...

November 2012
FROM

Breast Cancer - Pipeline Review, H1 2015

Breast Cancer - Pipeline Review, H1 2015 Summary This, ‘Breast Cancer - Pipeline Review, H1 2015’, provides an overview of the Breast Cancer’s therapeutic pipeline. This report provides comprehensive...

January 2015
FROM

Glaucoma - Pipeline Review, H1 2015

Glaucoma - Pipeline Review, H1 2015 Summary This, ‘Glaucoma - Pipeline Review, H1 2015’, provides an overview of the Glaucoma’s therapeutic pipeline. This report provides comprehensive information...

January 2015
FROM

Hypertension - Pipeline Review, H1 2014

Hypertension - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Hypertension - Pipeline Review, H1 2014’, provides an overview of the Hypertension’s therapeutic pipeline. This report provides...

February 2014
FROM

Healthcare, Regulatory and Reimbursement Landscape - Germany

Healthcare, Regulatory and Reimbursement Landscape - Germany Summary GlobalData, the industry analysis specialist, has released its new report, “Healthcare, Regulatory and Reimbursement Landscape...

February 2012
FROM

Glaucoma - Pipeline Review, H1 2014

Glaucoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Glaucoma - Pipeline Review, H1 2014’, provides an overview of the Glaucoma’s therapeutic pipeline. This report provides comprehensive...

February 2014
FROM

Breast Cancer - Pipeline Review, H1 2014

Breast Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Breast Cancer - Pipeline Review, H1 2014’, provides an overview of the Breast Cancer’s therapeutic pipeline. This report...

March 2014
FROM

Forest Laboratories, Inc. (FRX) - Financial and Strategic SWOT Analysis Review

Forest Laboratories, Inc. (FRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

June 2014
FROM

Glaucoma - Pipeline Review, H2 2014

Glaucoma - Pipeline Review, H2 2014 Summary This, ‘Glaucoma - Pipeline Review, H2 2014’, provides an overview of the Glaucoma’s therapeutic pipeline. This report provides comprehensive information...

July 2014
FROM
Loading Indicator

Our Clients

Procter & Gamble Co. Western Union Company Volvo Car Corporation Morgan Stanley SAP SE LG Corporation Roche Diagnostics Ltd.